Science
Mechanism of Action
This precision peptide operates by stimulating the biosynthesis of critical extracellular matrix components, including collagen, elastin, and glycosaminoglycans like hyaluronic acid. It promotes the proliferation of fibroblasts and keratinocytes, activates pathways such as TGF-β1, and influences ECM-receptor interactions, ultimately leading to a visibly thicker, firmer, and more elastic skin, with a reduction in the appearance of wrinkles.
Research
Clinical Evidence
Medium confidenceEffective concentrations in topical formulations typically range from 1% to 5% for direct application. Blended products (e.g., with Palmitoyl Tetrapeptide-7) have shown efficacy at 2-3%, while the pure powder can be used at 0.001-0.01%.
Key findings
- 01 A cream containing a palmitoyl oligopeptide complex significantly improved skin wrinkles and roughness by promoting cell proliferation and the biosynthesis of collagens and integrins. This effect was linked to the activation of key pathways like TGF-β1 and ECM-receptor interaction.
- 02 An anti-aging facial cream formulated with 1% palmitoyl oligopeptide was developed to effectively target and combat facial wrinkles.
- 03 In an in vivo study involving 24 volunteers (mean age 56.1 years), twice-daily application of a cream containing Matrixyl™ 3000 (a blend of palmitoyl oligopeptide and palmitoyl tetrapeptide-7) for two months resulted in significant skin rejuvenation.
Transparency
Dusting Analysis
Palmitoyl Oligopeptide demonstrates efficacy across a range of concentrations, with topical applications showing benefits from 1% to 5%, and powder forms effective even at 0.001-0.01%. This suggests that, while optimal performance is often observed at higher percentages, even lower concentrations can contribute to desired effects, making it less prone to 'dusting' when appropriately formulated.
The Formula
Formulation
Stability
For optimal stability, Palmitoyl Oligopeptide should be incorporated into formulations at the final stage, ensuring temperatures remain below 40 °C (or 45°C in certain systems). Products containing this ingredient require refrigerated storage (4-8°C / 39-46°F).
Synergies
- Palmitoyl Tetrapeptide-7 (as seen in Matrixyl™ 3000 for enhanced skin rejuvenation and dark circle reduction)
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel, in their 2012/2014 review, noted insufficient data for a comprehensive safety assessment of 'Palmitoyl Oligopeptides' as a broad category due to variability in peptide sequences and concerns regarding potential angiogenesis. Consequently, no general 'safe as used' conclusion was issued for the entire group. However, some specific palmitoyl peptides have been identified as well-tolerated and non-irritating in isolated studies.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Palmitoyl Oligopeptide is a valuable matrikine peptide demonstrating significant capabilities in enhancing skin firmness, elasticity, and reducing the appearance of wrinkles through collagen and elastin stimulation. However, its broad safety profile, as per CIR, necessitates further specific evaluation.
Related
Similar Ingredients
Finding similar ingredients…